Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 2,338 $ 2,815
Trading marketable securities 0 7,611
Prepaid expenses and other current assets 219 554
Total Current Assets 2,557 10,980
Operating lease right-of-use assets 99 21
Intangible asset 2,039 2,039
Other assets 3 3
TOTAL ASSETS 4,698 13,043
Current Liabilities    
Accounts payable and accrued liabilities 1,679 1,238
Due to related parties 61 30
Operating lease liabilities - current portion 35 23
Total Current Liabilities 1,772 1,291
Operating lease liabilities 69 0
TOTAL LIABILITIES 1,841 1,291
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized, 0 shares issued and outstanding as of December 31, 2024 and 2023 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized and 3,281,032 and 3,188,959 shares issued and outstanding as of December 31, 2024 and 2023, respectively 3 3
Additional paid-in capital 53,192 52,262
Accumulated deficit (50,136) (40,310)
Accumulated other comprehensive loss (202) (203)
TOTAL STOCKHOLDERS' EQUITY 2,857 11,752
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 4,698 $ 13,043